---
schema_version: "secwatch.filing_event.v1"
accession: "0001230245-26-000005"
form_type: "8-K"
ticker: "PIPR"
cik: "0001230245"
company_name: "PIPER SANDLER COMPANIES"
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T04:49:40.158748+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Piper Sandler elects Stuart M. Essig to board, effective Feb 4, 2026

## Summary
- Essig was CEO of Integra LifeSciences (1997-2012), growing revenue from ~$15M to $1.6B.
- Board expands to 10 directors; Essig appointed to Audit Committee.
- Compensation: pro-rated $100K cash retainer, $60K initial equity, $150K annual equity after 2026 meeting.
- Essig also serves on IDEXX Laboratories board; previously healthcare M&A banker at Goldman Sachs.

## SEC filing metadata
- accession: 0001230245-26-000005
- form_type: 8-K
- ticker: PIPR
- cik: 0001230245
- company_name: PIPER SANDLER COMPANIES
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1230245/000123024526000005/0001230245-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1230245/000123024526000005/pipr-20260204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001230245-26-000005
- JSON: https://secwatch.observer/filing/0001230245-26-000005.json
- Plain text: https://secwatch.observer/filing/0001230245-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.